Final Talks Commence on Completing Pandemic Treaty's Missing Piece
Negotiations Set to Last One Week Aim to Overcome Divisions on Pathogen Access and Benefit-Sharing System.
The World Health Organization (WHO) is set to commence an additional week of negotiations in order to complete the crucial missing piece of the international pandemic treaty.
The discussions, which began on Monday, are focusing on how the pandemic treaty, adopted last year, will operate in practice.
Wealthy countries and developing nations find themselves at odds over the implementation details.
The central component of the agreement that remains unresolved is the Pathogen Access and Benefit-Sharing (PABS) system.
This mechanism governs the sharing of access to pathogens with pandemic potential, as well as the subsequent benefits derived from them, including vaccines, tests, and treatments.
Developing countries express distrust regarding the equitable distribution of vaccines in a crisis scenario.
In contrast, some nations question the pharmaceutical industry's willingness and capacity to contribute to this global agreement without assurance of financial return.
Another significant challenge is integrating the sharing of genetic data, which has become as vital as the sharing of physical viruses for developing vaccines, treatments, and diagnostics.
The treaty aims at enhancing global coordination, surveillance, and access to vaccines by improving responses to future pandemics.
However, the PABS component was delayed during the initial negotiations to expedite adoption of the main agreement in May 2025.
Countries have until Friday to finalize this segment with the goal of securing its approval during the upcoming World Health Assembly scheduled for May 18.
Despite the significant differences, there is cautious optimism that a compromise can be reached.
The European Union has shown signs of flexibility, although finding common ground remains challenging.
Developing nations, particularly in Africa, view PABS as essential to prevent their exclusion from future vaccine distributions.
However, there are varying stances among these countries, with some advocating for technology transfers while others prioritize access to healthcare products.
Key issues that remain unresolved include mandatory rules for laboratories ensuring equitable access to vaccines and the establishment of a user registration system for the PABS database.
Developed countries propose maintaining anonymous access, which developing nations argue would hinder tracking and ensure accountability in the utilization and distribution of pathogen information.
The WHO is expected to address these contentious issues during the week-long negotiations as it seeks to strengthen global health governance post-pandemic.
The discussions, which began on Monday, are focusing on how the pandemic treaty, adopted last year, will operate in practice.
Wealthy countries and developing nations find themselves at odds over the implementation details.
The central component of the agreement that remains unresolved is the Pathogen Access and Benefit-Sharing (PABS) system.
This mechanism governs the sharing of access to pathogens with pandemic potential, as well as the subsequent benefits derived from them, including vaccines, tests, and treatments.
Developing countries express distrust regarding the equitable distribution of vaccines in a crisis scenario.
In contrast, some nations question the pharmaceutical industry's willingness and capacity to contribute to this global agreement without assurance of financial return.
Another significant challenge is integrating the sharing of genetic data, which has become as vital as the sharing of physical viruses for developing vaccines, treatments, and diagnostics.
The treaty aims at enhancing global coordination, surveillance, and access to vaccines by improving responses to future pandemics.
However, the PABS component was delayed during the initial negotiations to expedite adoption of the main agreement in May 2025.
Countries have until Friday to finalize this segment with the goal of securing its approval during the upcoming World Health Assembly scheduled for May 18.
Despite the significant differences, there is cautious optimism that a compromise can be reached.
The European Union has shown signs of flexibility, although finding common ground remains challenging.
Developing nations, particularly in Africa, view PABS as essential to prevent their exclusion from future vaccine distributions.
However, there are varying stances among these countries, with some advocating for technology transfers while others prioritize access to healthcare products.
Key issues that remain unresolved include mandatory rules for laboratories ensuring equitable access to vaccines and the establishment of a user registration system for the PABS database.
Developed countries propose maintaining anonymous access, which developing nations argue would hinder tracking and ensure accountability in the utilization and distribution of pathogen information.
The WHO is expected to address these contentious issues during the week-long negotiations as it seeks to strengthen global health governance post-pandemic.
